Rao, P.P.N.; Pham, A.T.; Shakeri, A.; El Shatshat, A.; Zhao, Y.; Karuturi, R.C.; Hefny, A.A.
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection. Pharmaceuticals 2021, 14, 44.
https://doi.org/10.3390/ph14010044
AMA Style
Rao PPN, Pham AT, Shakeri A, El Shatshat A, Zhao Y, Karuturi RC, Hefny AA.
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection. Pharmaceuticals. 2021; 14(1):44.
https://doi.org/10.3390/ph14010044
Chicago/Turabian Style
Rao, Praveen P. N., Amy Trinh Pham, Arash Shakeri, Amna El Shatshat, Yusheng Zhao, Rahul C. Karuturi, and Ahmed A. Hefny.
2021. "Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection" Pharmaceuticals 14, no. 1: 44.
https://doi.org/10.3390/ph14010044
APA Style
Rao, P. P. N., Pham, A. T., Shakeri, A., El Shatshat, A., Zhao, Y., Karuturi, R. C., & Hefny, A. A.
(2021). Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection. Pharmaceuticals, 14(1), 44.
https://doi.org/10.3390/ph14010044